Aligos Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALGS and other ETFs, options, and stocks.About ALGS
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH).
CEOLawrence M. Blatt
CEOLawrence M. Blatt
Employees70
Employees70
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2018
Founded2018
Employees70
Employees70
ALGS Key Statistics
Market cap61.51M
Market cap61.51M
Price-Earnings ratio-0.51
Price-Earnings ratio-0.51
Dividend yield—
Dividend yield—
Average volume72.77K
Average volume72.77K
High today$10.50
High today$10.50
Low today$9.84
Low today$9.84
Open price$10.12
Open price$10.12
Volume33.74K
Volume33.74K
52 Week high$46.80
52 Week high$46.80
52 Week low$3.76
52 Week low$3.76
Stock Snapshot
Aligos Therapeutics(ALGS) stock is priced at $9.99, giving the company a market capitalization of 61.51M. It carries a P/E multiple of -0.51.
As of 2025-12-07, Aligos Therapeutics(ALGS) stock has fluctuated between $9.84 and $10.50. The current price stands at $9.99, placing the stock +1.5% above today's low and -4.9% off the high.
Aligos Therapeutics(ALGS) shares are trading with a volume of 33.74K, against a daily average of 72.77K.
In the last year, Aligos Therapeutics(ALGS) shares hit a 52-week high of $46.80 and a 52-week low of $3.76.
In the last year, Aligos Therapeutics(ALGS) shares hit a 52-week high of $46.80 and a 52-week low of $3.76.
People also own
Based on the portfolios of people who own ALGS. This list is generated using Robinhood data, and it’s not a recommendation.